Case Reports
doi: 10.1128/JCM.05966-11.
Epub 2012 Jan 25.
Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India
Affiliations
- PMID: 22278840
- PMCID: PMC3318524
- DOI: 10.1128/JCM.05966-11
Item in Clipboard
Case Reports
Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India
J Clin Microbiol.
2012 Apr.
Abstract
Post kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that usually develops after treatment of visceral leishmaniasis (VL), a major public health problem in India. The diagnosis and management of PKDL is complex. This is the first case report from India in which PKDL occurred after paromomycin treatment for VL in an Indian patient.
Similar articles
-
Advanced case of PKDL due to delayed treatment: A rare case report.PLoS Negl Trop Dis. 2020 Mar 23;14(3):e0008052. doi: 10.1371/journal.pntd.0008052. eCollection 2020 Mar. PLoS Negl Trop Dis. 2020. PMID: 32203500 Free PMC article.
-
Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.Infect Dis Poverty. 2018 Aug 13;7(1):80. doi: 10.1186/s40249-018-0461-0. Infect Dis Poverty. 2018. PMID: 30099967 Free PMC article.
-
Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12. Trop Med Int Health. 2012. PMID: 22882665
-
Challenges in the diagnosis of post kala-azar dermal leishmaniasis.Indian J Med Res. 2006 Mar;123(3):295-310. Indian J Med Res. 2006. PMID: 16778312 Review.
-
Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.BMC Infect Dis. 2015 Nov 23;15:543. doi: 10.1186/s12879-015-1260-x. BMC Infect Dis. 2015. PMID: 26592919 Free PMC article. Review.
Cited by
-
Active surveillance identified a neglected burden of macular cases of Post Kala-azar Dermal Leishmaniasis in West Bengal.PLoS Negl Trop Dis. 2019 Mar 11;13(3):e0007249. doi: 10.1371/journal.pntd.0007249. eCollection 2019 Mar. PLoS Negl Trop Dis. 2019. PMID: 30856178 Free PMC article.
-
Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.Front Immunol. 2023 Aug 11;14:1236952. doi: 10.3389/fimmu.2023.1236952. eCollection 2023. Front Immunol. 2023. PMID: 37638047 Free PMC article. Review.
-
Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from Bangladesh.PLoS Negl Trop Dis. 2019 Aug 15;13(8):e0007653. doi: 10.1371/journal.pntd.0007653. eCollection 2019 Aug. PLoS Negl Trop Dis. 2019. PMID: 31415565 Free PMC article.
-
Combination Therapy Against Indian Visceral Leishmaniasis with Liposomal Amphotericin B (FungisomeTM) and Short-Course Miltefosine in Comparison to Miltefosine Monotherapy.Am J Trop Med Hyg. 2020 Jul;103(1):308-314. doi: 10.4269/ajtmh.19-0931. Epub 2020 May 7. Am J Trop Med Hyg. 2020. PMID: 32394874 Free PMC article. Clinical Trial.
-
Leishmaniasis: where are we and where are we heading?Parasitol Res. 2021 May;120(5):1541-1554. doi: 10.1007/s00436-021-07139-2. Epub 2021 Apr 7. Parasitol Res. 2021. PMID: 33825036 Review.
References
-
- Das VNR, et al. 2009. Development of post kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis. Am. J. Trop. Med. Hyg. 80:336–338 - PubMed
-
- Dutta M, Ghosh TK. 1983. Review of current status of leishmaniasis epidemiology, p 97–102 Proceedings of the Indo-UK Workshop on Leishmaniasis Indian Council of Medical Research, New Delhi, India
-
- Singh S, Sundar S. 1995. Treatment of post-kala-azar dermal leishmaniasis. Int. J. Dermatol. 34:668–669 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
